Endo-Munoz Liliana, Evdokiou Andreas, Saunders Nicholas A
The University of Queensland Diamantina Institute, Brisbane, Australia.
Biochim Biophys Acta. 2012 Dec;1826(2):434-42. doi: 10.1016/j.bbcan.2012.07.003. Epub 2012 Jul 27.
Osteosarcoma (OS) is the most common primary bone tumour in the paediatric age group. Treatment-refractory pulmonary metastasis continues to be the major complication of OS, reducing the 5-year survival rate for these patients to 10-20%. The mechanisms underlying the metastatic process in OS are still unclear, but undoubtedly, a greater understanding of the factors and interactions involved in its regulation will open new and much needed opportunities for therapeutic intervention. Recent published data have identified a new role for bone-specific macrophages (osteoclasts) and tumour-associated macrophages (TAMs), in OS metastasis. In this review we discuss the contribution of TAMs and osteoclasts in the establishment and maintenance of secondary metastatic lesions, and their novel role in the prevention of metastatic disease in a primary bone cancer such as osteosarcoma.
骨肉瘤(OS)是儿童年龄组中最常见的原发性骨肿瘤。难治性肺转移仍然是骨肉瘤的主要并发症,使这些患者的5年生存率降至10%-20%。骨肉瘤转移过程的潜在机制仍不清楚,但毫无疑问,更深入了解其调控过程中涉及的因素和相互作用,将为治疗干预带来新的、急需的机会。最近发表的数据确定了骨特异性巨噬细胞(破骨细胞)和肿瘤相关巨噬细胞(TAM)在骨肉瘤转移中的新作用。在这篇综述中,我们讨论了TAM和破骨细胞在继发性转移灶的形成和维持中的作用,以及它们在预防骨肉瘤等原发性骨癌转移疾病中的新作用。